Webinar: Integrating ReproTracker into DART AOPs for mechanism-based teratogenicity assessment

ReproTracker devtox

Webinar: Integrating ReproTracker into DART AOPs for mechanism-based teratogenicity assessment

On the 20th of June, we hosted a webinar entitled “Integrating ReproTracker into DART AOPs for mechanism-based teratogenicity assessment”. In this webinar, we illustrated how the information from adverse outcome pathway (AOP) networks complements the in vitro human-based assay ReproTracker for DART assessments and supports decision-making for chemical safety.

Please click here to request the webinar from us.

About ReproTracker

ReproTracker® is a state-of-the-art human stem cell-based in vitro assay that rapidly and reliably identifies developmental toxicity hazards of new drugs and chemicals. The assay captures the key cellular events of stem cell differentiation and early embryonic development. ReproTracker is used to investigate if compounds interfere with early embryonic development and the assay can quantitatively predict their teratogenic potential. ReproTracker can be used as an early-phase developmental toxicity screening platform, an alternative for animal-free teratogenicity testing of materials, or as a tool to extrapolate animal-derived results to humans.

No Comments

Leave a reply